Significant improvements in mechanistic biomarkers of how Dialive™ improves organ function
About EASL and the ALIVER Consortium The ALIVER Consortium of 11 institutions from seven European countries developed an innovative liver dialysis machine called Dialive™. This device helps the liver to regenerate naturally…
Looking towards bright horizons for 2021
This year has been unlike any other. COVID-19 brought unimaginable challenges to the medical community, placing you at the forefront of the pandemic. The year 2020 posed unique questions to those of…
Call for nominations for two new Scientific Committee members to join the EASL Governing Board
Are you deeply engaged in both hepatology and science and ready to get involved in EASL’s governance? EASL is now calling for nomination of two new Scientific Committee members to join the Governing Board. The term for these members is…
Study identifies causes precipitating the most serious stage of cirrhosis
Researchers from EF Clif identify the causes that precipitate the onset of the most serious stage of cirrhosis: the syndrome of Acute-On-Chronic Liver Failure (ACLF). Barcelona, December 9, 2020 – A new investigation…
EASL engages in Awareness Week on Alcohol-Related Harm 2020
Awareness Week on Alcohol-Related Harm (AWARH) takes place yearly. It serves to raise awareness among EU policymakers of the types of harm caused by alcohol, to increase awareness about the need to…
Register now for EASL Members’ Extraordinary General Assembly – 10 December 2020, 14:00–16:00 CET
An extraordinary year, such as 2020, calls for increased connection with and accountability to our community. EASL wants to hear from you, our members, about what you want and need from us…
Announcing the winners of our #EASLshare competition
As a fully digital three-day event, Digital ILC 2020 brought together thousands of delegates from all over the world. EASL invited you, the delegates, to take part in the first ever EASL…
